{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:58:49Z","timestamp":1781265529025,"version":"3.54.1"},"reference-count":97,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100010558","name":"Beiersdorf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010558","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Hyperpigmentation disorders are prevalent in individuals with skin of color and are associated with considerable psychosocial impact. Clinical heterogeneity, chronic relapsing course, and limited evidence often result in suboptimal outcomes. This consensus aimed to develop evidence\u2010informed, expert consensus recommendations for the diagnosis and management of common hyperpigmentation disorders in the Indian context. A modified Delphi study was conducted by Indian experts of the Pigmentary Disorders Society (PDS) between August 2025 and January 2026. Twelve dermatologists with expertize in pigmentary disorders participated. An exploratory round identified four priority conditions: melasma, acquired dermal macular hyperpigmentation, post\u2010inflammatory hyperpigmentation, and periorbital hyperpigmentation. A broad literature review informed the development of the statements. Two rounds of anonymous voting using a 5\u2010point Likert scale and a virtual meeting were undertaken. Consensus was predefined as high (\u2265\u200975%), moderate (55%\u201374%), or low (&lt;\u200955%). In Round 1, 34 statements were evaluated; 21 achieved high consensus, 9 moderate, and 4 low. Following the virtual discussion and refinement, 11 revised statements were revoted on in Round 2, resulting in 32 final high\u2010consensus statements. Key recommendations emphasized proactive prevention and relapse minimization in Fitzpatrick skin types III\u2013VI, the use of dermoscopy and Wood's lamp for aiding diagnosis, and the use of histopathology when indicated. Overall, the consensus favored combination approaches targeting melanogenesis, inflammation, and photoprotection. The panel also outlined preferred topical, oral, and procedural options based on existing evidence and clinical experience. Overall, this consensus provides contextualized guidance for major hyperpigmentation disorders, emphasizing individualized and multimodal management.<\/jats:p>\n                  <jats:p>\n                    <jats:boxed-text content-type=\"graphic\" position=\"anchor\">\n                      <jats:graphic xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" mimetype=\"image\/png\" position=\"anchor\" specific-use=\"enlarged-web-image\" xlink:href=\"graphic\/ijd70531-gra-0001-m.png\">\n                        <jats:alt-text>image<\/jats:alt-text>\n                      <\/jats:graphic>\n                    <\/jats:boxed-text>\n                  <\/jats:p>","DOI":"10.1111\/ijd.70531","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:21:18Z","timestamp":1781263278000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expert Consensus on the Management of Hyperpigmentation Disorders in India: A Modified Delphi Study by the Pigmentary Disorders Society"],"prefix":"10.1111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8768-4879","authenticated-orcid":false,"given":"Rashmi","family":"Sarkar","sequence":"first","affiliation":[{"name":"Department of Dermatology Vardhman Mahavir Medical College (VMMC) and Safdarjung Hospital  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9912-0085","authenticated-orcid":false,"given":"Sunil","family":"Dogra","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology Postgraduate Institute of Medical Education and Research (PGIMER)  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0423-7588","authenticated-orcid":false,"given":"Surabhi","family":"Sinha","sequence":"additional","affiliation":[{"name":"Department of Dermatology Lady Hardinge Medical College &amp; Associated SSK and KSC Hospitals  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6323-4988","authenticated-orcid":false,"given":"Keshavamurthy","family":"Vinay","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology Postgraduate Institute of Medical Education and Research (PGIMER)  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-083X","authenticated-orcid":false,"given":"Indrashis","family":"Podder","sequence":"additional","affiliation":[{"name":"Department of Dermatology College of Medicine and Sagore Dutta Hospital  Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0841-9597","authenticated-orcid":false,"given":"Anupam","family":"Das","sequence":"additional","affiliation":[{"name":"Department of Dermatology KPC Medical College and Hospital  Kolkata India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8845-283X","authenticated-orcid":false,"given":"Bhavesh","family":"Swarnkar","sequence":"additional","affiliation":[{"name":"Department of Dermatology Swarnkar Superspeciality Center  Indore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-8875","authenticated-orcid":false,"given":"B. S.","family":"Chandrashekar","sequence":"additional","affiliation":[{"name":"Department of Dermatology CUTIS Academy of Cutaneous Sciences  Bangalore India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7481-2330","authenticated-orcid":false,"given":"Hitaishi","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology Postgraduate Institute of Medical Education and Research (PGIMER)  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8122-0368","authenticated-orcid":false,"given":"Madhuri","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Department of Dermatology Yavana Skin &amp; Hair Clinic  Mumbai India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8091-101X","authenticated-orcid":false,"given":"Muthu Sendhil","family":"Kumaran","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Venereology and Leprology Postgraduate Institute of Medical Education and Research (PGIMER)  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2180-3451","authenticated-orcid":false,"given":"Sonali","family":"Langar","sequence":"additional","affiliation":[{"name":"Department of Dermatology &amp; Cosmetology Skin Remedies Clinic and Laser Center  Noida India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3022-5169","authenticated-orcid":false,"given":"Seemal R.","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of Texas Southwestern Medical Center  Dallas Texas USA"},{"name":"Innovative Dermatology  Plano Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s13555-023-00915-1","article-title":"Self\u2010Esteem, Depression, Anxiety and Quality of Life in Patients With Melasma Living in a Sunny Mediterranean Area: Results From a Prospective Cross\u2010Sectional Study","volume":"13","author":"Platsidaki E.","year":"2023","journal-title":"Dermatology and Therapy"},{"key":"e_1_2_12_3_1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7573\/dic.2021-11-2","article-title":"Dermatology: How to Manage Facial Hyperpigmentation in Skin of Colour","volume":"11","author":"Moolla S.","year":"2022","journal-title":"Drugs Context"},{"key":"e_1_2_12_4_1","doi-asserted-by":"crossref","first-page":"4839","DOI":"10.3390\/molecules28124839","article-title":"Skin Pigmentation Types, Causes and Treatment\u2010A Review","volume":"28","author":"Thawabteh A. M.","year":"2023","journal-title":"Molecules"},{"key":"e_1_2_12_5_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ced.14747","article-title":"Differential Diagnosis and Management of Hyperpigmentation","volume":"47","author":"Yoo J.","year":"2022","journal-title":"Clinical and Experimental Dermatology"},{"key":"e_1_2_12_6_1","volume-title":"Postinflammatory Hyperpigmentation","author":"Lawrence E.","year":"2025"},{"key":"e_1_2_12_7_1","first-page":"797","article-title":"Pigmentation Disorders: Diagnosis and Management","volume":"96","author":"Plensdorf S.","year":"2017","journal-title":"American Family Physician"},{"key":"e_1_2_12_8_1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.36849\/JDD.8519","article-title":"The Impact of Hyperpigmentation on the Lives of Patients","volume":"24","author":"Wang J. Y.","year":"2025","journal-title":"Journal of Drugs in Dermatology"},{"key":"e_1_2_12_9_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4103\/0974-2077.104912","article-title":"Chemical Peels for Melasma in Dark\u2010Skinned Patients","volume":"5","author":"Sarkar R.","year":"2012","journal-title":"Journal of Cutaneous and Aesthetic Surgery"},{"key":"e_1_2_12_10_1","doi-asserted-by":"crossref","DOI":"10.3390\/cosmetics10010025","article-title":"Treatment of Melasma on Darker Skin Types: A Scoping Review","volume":"10","author":"Mpofana N.","year":"2023","journal-title":"Cosmetics"},{"key":"e_1_2_12_11_1","first-page":"13","article-title":"Hyperpigmentation Therapy: A Review","volume":"7","author":"Desai S. R.","year":"2014","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"e_1_2_12_12_1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1177\/12034754241265716","article-title":"Treatment of Post\u2010Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review","volume":"28","author":"Mar K.","year":"2024","journal-title":"Journal of Cutaneous Medicine and Surgery"},{"key":"e_1_2_12_13_1","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/pcmr.12986","article-title":"Management of Hyperpigmentation: Current Treatments and Emerging Therapies","volume":"34","author":"Nautiyal A.","year":"2021","journal-title":"Pigment Cell & Melanoma Research"},{"key":"e_1_2_12_14_1","doi-asserted-by":"crossref","first-page":"116","DOI":"10.5662\/wjm.v11.i4.116","article-title":"Delphi Methodology in Healthcare Research: How to Decide Its Appropriateness","volume":"11","author":"Nasa P.","year":"2021","journal-title":"World Journal of Methodology"},{"key":"e_1_2_12_15_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004326","article-title":"ACCORD (ACcurate COnsensus Reporting Document): A Reporting Guideline for Consensus Methods in Biomedicine Developed via a Modified Delphi","volume":"21","author":"Gattrell W. T.","year":"2024","journal-title":"PLoS Medicine"},{"key":"e_1_2_12_16_1","volume-title":"Levels of Evidence (March 2009)","author":"Oxford Centre for Evidence\u2010Based Medicine","year":"2020"},{"key":"e_1_2_12_17_1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/ajd.14432","article-title":"Prevention of Post\u2010Inflammatory Hyperpigmentation in Skin of Colour: A Systematic Review","volume":"66","author":"Mar K.","year":"2025","journal-title":"Australasian Journal of Dermatology"},{"key":"e_1_2_12_18_1","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1097\/CM9.0000000000001009","article-title":"Dermoscopy Combined With Wood Lamp, a Diagnostic Alternative for Five Pigmented Lesions on the Face: An Observational Study","volume":"133","author":"Lu Q. S.","year":"2020","journal-title":"Chinese Medical Journal"},{"key":"e_1_2_12_19_1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.4103\/0378-6323.110798","article-title":"Clinicopathological Correlation of Acquired Hyperpigmentary Disorders","volume":"79","author":"Patel A. B.","year":"2013","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","DOI":"10.4103\/Pigmentinternational.Pigmentinternational_39_19","article-title":"Clinico\u2010Dermatoscopic and Histopathological Evaluation of Cervico\u2010Facial Hypermelanosis: A Study From a Tertiary Care Hospital","volume":"7","author":"Kaur S.","year":"2020","journal-title":"Pigment International"},{"key":"e_1_2_12_21_1","first-page":"697","article-title":"A Randomized Controlled Trial of the Efficacy and Safety of a Fixed Triple Combination (Fluocinolone Acetonide 0.01%, Hydroquinone 4%, Tretinoin 0.05%) Compared With Hydroquinone 4% Cream in Asian Patients With Moderate to Severe Melasma","volume":"159","author":"Chan R.","year":"2008","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_12_22_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15107","article-title":"Topical 5% Tranexamic Acid With 30% Glycolic Acid Peel: An Useful Combination for Accelerating the Improvement in Melasma","volume":"34","author":"Sahu P.","year":"2021","journal-title":"Dermatologic Therapy"},{"key":"e_1_2_12_23_1","first-page":"828","article-title":"The Combination of Glycolic Acid Peels With a Topical Regimen in the Treatment of Melasma in Dark\u2010Skinned Patients: A Comparative Study","volume":"28","author":"Sarkar R.","year":"2002","journal-title":"Dermatologic Surgery"},{"key":"e_1_2_12_24_1","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jaad.2021.03.116","article-title":"Microneedling as an Adjuvant to Topical Therapies for Melasma: A Systematic Review and Meta\u2010Analysis","volume":"86","author":"Bailey A. J. M.","year":"2022","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_12_25_1","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1111\/jocd.16006","article-title":"Efficacy and Safety of Laser\u2010Related Therapy for Melasma: A Systematic Review and Network Meta\u2010Analysis","volume":"22","author":"Ma W.","year":"2023","journal-title":"Journal of Cosmetic Dermatology"},{"key":"e_1_2_12_26_1","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1007\/s00403-023-02549-x","article-title":"A Randomized, Open\u2010Label Study to Compare Two Different Dosing Regimens of Oral Tranexamic Acid in Treatment of Moderate to Severe Facial Melasma","volume":"315","author":"Bhattacharjee R.","year":"2023","journal-title":"Archives of Dermatological Research"},{"key":"e_1_2_12_27_1","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.jaad.2017.09.053","article-title":"Randomized, Placebo\u2010Controlled, Double\u2010Blind Study of Oral Tranexamic Acid in the Treatment of Moderate\u2010To\u2010Severe Melasma","volume":"78","author":"Del Rosario E.","year":"2018","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_12_28_1","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ced\/llae226","article-title":"Assessing the Efficacy of Oral Tranexamic Acid as an Adjuvant to Triple Combination Topical Treatment in Melasma: A Meta\u2010Analysis of Randomized Controlled Trials","volume":"49","author":"Ribeiro Gon\u00e7alves O.","year":"2024","journal-title":"Clinical and Experimental Dermatology"},{"key":"e_1_2_12_29_1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s13555-014-0064-z","article-title":"Evidence\u2010Based Treatment for Melasma: Expert Opinion and a Review","volume":"4","author":"Shankar K.","year":"2014","journal-title":"Dermatology and Therapy"},{"key":"e_1_2_12_30_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.25259\/IJDVL_804_2021","article-title":"A Delphi Consensus on the Nomenclature and Diagnosis of Lichen Planus Pigmentosus and Related Entities","volume":"89","author":"Sarkar R.","year":"2023","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"e_1_2_12_31_1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4103\/ijd.IJD_559_19","article-title":"Patch Testing as a Corroborative and Diagnostic Tool in Patients Suspected of Contact Allergen Induced Facial Melanosis","volume":"66","author":"Ghuse V. M.","year":"2021","journal-title":"Indian Journal of Dermatology"},{"key":"e_1_2_12_32_1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1468-3083.2009.03460.x","article-title":"Clinicopathological Characteristics of Lichen Planus Pigmentosus and Its Response to Tacrolimus Ointment: An Open Label, Non\u2010Randomized, Prospective Study","volume":"24","author":"Al\u2010Mutairi N.","year":"2010","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_12_33_1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/ajd.13567","article-title":"Oral Mycophenolate Mofetil in the Treatment of Acquired Dermal Macular Hyperpigmentation: An Open\u2010Label Pilot Study","volume":"62","author":"Bishnoi A.","year":"2021","journal-title":"Australasian Journal of Dermatology"},{"key":"e_1_2_12_34_1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/jocd.12797","article-title":"A Pilot Study of Oral Tranexamic Acid and Glycyrrhizin Compound in the Treatment of Recalcitrant Riehl's Melanosis","volume":"18","author":"Xu Z.","year":"2019","journal-title":"Journal of Cosmetic Dermatology"},{"key":"e_1_2_12_35_1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/ijd.13293","article-title":"Low\u2010Dose Oral Isotretinoin Therapy in Lichen Planus Pigmentosus: An Open\u2010Label Non\u2010Randomized Prospective Pilot Study","volume":"55","author":"Muthu S. K.","year":"2016","journal-title":"International Journal of Dermatology"},{"key":"e_1_2_12_36_1","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/jocd.12862","article-title":"Modified Phenol Peels for Treatment\u2010Refractory Hyperpigmentation of Lichen Planus Pigmentosus: A Retrospective Clinico\u2010Dermoscopic Analysis","volume":"18","author":"Sonthalia S.","year":"2019","journal-title":"Journal of Cosmetic Dermatology"},{"key":"e_1_2_12_37_1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jocd.13153","article-title":"Combination Therapy With Salicylic Acid Chemical Peels, Glycyrrhizin Compound, and Vitamin C for Riehl's Melanosis","volume":"19","author":"Wang L.","year":"2020","journal-title":"Journal of Cosmetic Dermatology"},{"key":"e_1_2_12_38_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.13208","article-title":"Effect of Q\u2010Switched Nd\u2010YAG Laser on the Clinical, Pigmentary, and Immunological Markers in Patients With Lichen Planus Pigmentosus: A Pilot Study","volume":"33","author":"Bhari N.","year":"2020","journal-title":"Dermatologic Therapy"},{"key":"e_1_2_12_39_1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1080\/14764172.2018.1469770","article-title":"An Open\u2010Label Non\u2010Randomized Prospective Pilot Study of the Efficacy of Q\u2010Switched Nd\u2010YAG Laser in Management of Facial Lichen Planus Pigmentosus","volume":"21","author":"Shah D. S. D.","year":"2019","journal-title":"Journal of Cosmetic and Laser Therapy"},{"key":"e_1_2_12_40_1","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2147\/CCID.S385162","article-title":"Post\u2010Inflammatory Hyperpigmentation in Dark Skin: Molecular Mechanism and Skincare Implications","volume":"15","author":"Markiewicz E.","year":"2022","journal-title":"Clinical, Cosmetic and Investigational Dermatology"},{"key":"e_1_2_12_41_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18203\/issn.2455-4529.IntJResDermatol20195199","article-title":"Effectiveness of a Combination of Anti\u2010Pigmentary Products in Facial Post\u2010Inflammatory Hyperpigmentation","volume":"6","author":"Nayak C. S.","year":"2019","journal-title":"International Journal of Research in Dermatology"},{"key":"e_1_2_12_42_1","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/DSS.0000000000001007","article-title":"Treatment of Postinflammatory Hyperpigmentation With a Combination of Glycolic Acid Peels and a Topical Regimen in Dark\u2010Skinned Patients: A Comparative Study","volume":"43","author":"Sarkar R.","year":"2017","journal-title":"Dermatologic Surgery"},{"key":"e_1_2_12_43_1","first-page":"1","article-title":"A Retrospective Analysis of the Management of Acne Post\u2010Inflammatory Hyperpigmentation Using Topical Treatment, Laser Treatment, or Combination Topical and Laser Treatments in Oriental Patients","volume":"43","author":"Ho S. G. Y.","year":"2011","journal-title":"Lasers in Surgery and Medicine"},{"key":"e_1_2_12_44_1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0019-5154.127675","article-title":"Periorbital Hyperpigmentation: A Study of Its Prevalence, Common Causative Factors and Its Association With Personal Habits and Other Disorders","volume":"59","author":"Sheth P. B.","year":"2014","journal-title":"Indian Journal of Dermatology"},{"key":"e_1_2_12_45_1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/JCAS.JCAS_109_21","article-title":"Clinical and Dermoscopic Evaluation of Periorbital Melanosis","volume":"15","author":"Mahesh A. R.","year":"2022","journal-title":"Journal of Cutaneous and Aesthetic Surgery"},{"key":"e_1_2_12_46_1","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/DSS.0000000000002484","article-title":"Treatments of Periorbital Hyperpigmentation: A Systematic Review","volume":"47","author":"Michelle L.","year":"2021","journal-title":"Dermatologic Surgery"},{"key":"e_1_2_12_47_1","first-page":"49","article-title":"Periorbital Hyperpigmentation: A Comprehensive Review","volume":"9","author":"Sarkar R.","year":"2016","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"e_1_2_12_48_1","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/0019-5154.185707","article-title":"A Comparative Study of Two Modalities, 4% Hydroquinone Versus 30% Salicylic Acid in Periorbital Hyperpigmentation and Assessment of Quality of Life Before and After Treatment","volume":"61","author":"Ranjan R.","year":"2016","journal-title":"Indian Journal of Dermatology"},{"key":"e_1_2_12_49_1","doi-asserted-by":"crossref","DOI":"10.1111\/jocd.70326","article-title":"Clinical Efficacy of a Novel Topical Formulation on Periorbital Dark Circles: An Objective Analysis","volume":"24","author":"Brady R. T.","year":"2025","journal-title":"Journal of Cosmetic Dermatology"},{"key":"e_1_2_12_50_1","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jocd.13292","article-title":"Ferulic Acid 12% Peel: An Innovative Peel for Constitutional Type of Periorbital Melanosis\u2010Comparing Clinical Efficacy and Safety With 20% Glycolic Peel and 15% Lactic Peel","volume":"19","author":"Dayal S.","year":"2020","journal-title":"Journal of Cosmetic Dermatology"},{"key":"e_1_2_12_51_1","doi-asserted-by":"crossref","DOI":"10.34172\/jlms.2022.16","article-title":"Evaluation of Efficacy and Safety of Low\u2010Fluence Q\u2010Switched 1064\u2010Nm Laser in Infra\u2010Orbital Hyperpigmentation Based on Biometric Parameters","volume":"13","author":"Alavi S.","year":"2022","journal-title":"Journal of Lasers in Medical Sciences"},{"key":"e_1_2_12_52_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/jdv.70185","article-title":"Global Consensus on the Management of Melanin Hyperpigmentation Disorders","volume":"40","author":"Passeron T.","year":"2025","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"key":"e_1_2_12_53_1","doi-asserted-by":"crossref","DOI":"10.1111\/phpp.12937","article-title":"Evaluation of the Protection of Sunscreen Products Against Long Wavelength Ultraviolet A1 and Visible Light\u2010Induced Biological Effects","volume":"40","author":"Ezekwe N.","year":"2024","journal-title":"Photodermatology, Photoimmunology & Photomedicine"},{"key":"e_1_2_12_54_1","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/bjd.15940","article-title":"Synergistic Effects of Long\u2010Wavelength Ultraviolet A1 and Visible Light on Pigmentation and Erythema","volume":"178","author":"Kohli I.","year":"2018","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_12_55_1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/bjd.21850","article-title":"Is It Necessary to Wear Sunscreen Indoors?","volume":"187","author":"Diffey B. L.","year":"2022","journal-title":"British Journal of Dermatology"},{"key":"e_1_2_12_56_1","doi-asserted-by":"crossref","DOI":"10.3390\/antiox12010138","article-title":"Antioxidants in Sunscreens: Which and What for?","volume":"12","author":"Jesus A.","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"e_1_2_12_57_1","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jaad.2023.07.1045","article-title":"Best Practices in the Treatment of Melasma With a Focus on Patients With Skin of Color","volume":"90","author":"Desai S. R.","year":"2024","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_12_58_1","first-page":"79","article-title":"Clinico\u2010Dermoscopic Study and Comparative Evaluation With Wood's Lamp as a Diagnostic Tool in Patients With Melasma","volume":"11","author":"Khadka A.","year":"2024","journal-title":"Pigment International"},{"key":"e_1_2_12_59_1","first-page":"3","article-title":"Research Techniques Made Simple: Cutaneous Colorimetry: A Reliable Technique for Objective Skin Color Measurement","volume":"140","author":"Ly B. C. K.","year":"2020","journal-title":"Journal of Investigative Dermatology"},{"key":"e_1_2_12_60_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/pigmentinternational_16_25","article-title":"How Artificial Intelligence Is Transforming Pigmentary Dermatology\u2014An Overview","volume":"12","author":"Dey P.","year":"2025","journal-title":"Pigment International"},{"key":"e_1_2_12_61_1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaad.2024.07.1135","article-title":"Prevalence of Melasma, Impact on Quality of Life and Social Stigmatization: Results of the First Large International Survey","volume":"91","author":"Kerob D. K.","year":"2024","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_12_62_1","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/ijd.14541","article-title":"Clinical and Epidemiologic Features of Melasma: A Multicentric Cross\u2010Sectional Study From India","volume":"58","author":"Sarkar R.","year":"2019","journal-title":"International Journal of Dermatology"},{"key":"e_1_2_12_63_1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/der2.144","article-title":"Differential Diagnosis of Melasma and Hyperpigmentation","volume":"4","author":"Honigman A.","year":"2023","journal-title":"Dermatology Review"},{"key":"e_1_2_12_64_1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/JD9.0000000000000164","article-title":"Consensus on the Diagnosis and Treatment of Melasma in China","volume":"4","author":"Gao T. W.","year":"2021","journal-title":"International Journal of Dermatology and Venereology"},{"key":"e_1_2_12_65_1","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/pcmr.12404","article-title":"Recent Progress in Melasma Pathogenesis","volume":"28","author":"Lee A. Y.","year":"2015","journal-title":"Pigment Cell & Melanoma Research"},{"key":"e_1_2_12_66_1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamadermatol.2016.1006","article-title":"Interpretability of the Modified Melasma Area and Severity Index (mMASI)","volume":"152","author":"Rodrigues M.","year":"2016","journal-title":"JAMA Dermatology"},{"key":"e_1_2_12_67_1","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1111\/jdv.17344","article-title":"Efficacy and Safety of Topical Isobutylamido Thiazolyl Resorcinol (Thiamidol) vs. 4% Hydroquinone Cream for Facial Melasma: An Evaluator\u2010Blinded, Randomized Controlled Trial","volume":"35","author":"Lima P. B.","year":"2021","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_12_68_1","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s13555-025-01473-4","article-title":"Efficacy and Tolerability of a New Facial 2\u2010Mercaptonicotinoyl Glycine\u2010Containing Depigmenting Serum Versus Hydroquinone 4% Over 3\u2010Month Treatment of Facial Melasma","volume":"15","author":"Passeron T.","year":"2025","journal-title":"Dermatologic Therapy (Heidelberg)"},{"key":"e_1_2_12_69_1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00403-024-03571-3","article-title":"Efficacy and Safety of Cysteamine 5% Cream for the Management of Melasma: A Systematic Review and Meta\u2010Analysis of Randomized Controlled Trials","volume":"317","author":"Mawu F. O.","year":"2024","journal-title":"Archives of Dermatological Research"},{"key":"e_1_2_12_70_1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.4103\/idoj.idoj_616_24","article-title":"Efficacy and Safety of Cysteamine in Melasma in Patients of Skin of Colour: A Brief Report","volume":"16","author":"Sarkar R.","year":"2025","journal-title":"Indian Dermatology Online Journal"},{"key":"e_1_2_12_71_1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.4103\/idoj.idoj_1170_24","article-title":"Thiamidol in Melasma in Patients of Skin of Color: A Preliminary Report of Efficacy and Safety","volume":"16","author":"Sarkar R.","year":"2025","journal-title":"Indian Dermatology Online Journal"},{"key":"e_1_2_12_72_1","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1111\/jdv.19455","article-title":"Efficacy and Safety of a Novel Triple Combination Cream Compared to Kligman's Trio for Melasma: A 24\u2010Week Double\u2010Blind Prospective Randomized Controlled Trial","volume":"37","author":"Bertold C.","year":"2023","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_12_73_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.25259\/IJDVL_1157_2022","article-title":"Prescribing Practices of Tranexamic Acid for Melasma: Delphi Consensus From the Pigmentary Disorders Society","volume":"90","author":"Sarkar R.","year":"2023","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"e_1_2_12_74_1","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/jdv.70066","article-title":"Delphi Consensus on Melasma Management by International Experts and Pigmentary Disorders Society","volume":"40","author":"Sarkar R.","year":"2026","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_12_75_1","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1080\/09546634.2021.1914313","article-title":"Melasma Treatment: A Systematic Review","volume":"33","author":"Neagu N.","year":"2022","journal-title":"Journal of Dermatological Treatment"},{"key":"e_1_2_12_76_1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/der2.169","article-title":"Chemical Peels for the Management of Melasma and Hyperpigmentation","volume":"4","author":"Karim M.","year":"2023","journal-title":"Dermatology Review"},{"key":"e_1_2_12_77_1","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14693","article-title":"Most Worthwhile Superficial Chemical Peel for Melasma of Skin of Color: Authors' Experience of Glycolic, Trichloroacetic Acid, and Lactic Peel","volume":"34","author":"Sahu P.","year":"2021","journal-title":"Dermatologic Therapy"},{"key":"e_1_2_12_78_1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/DSS.0000000000000642","article-title":"Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma","volume":"42","author":"Sarkar R.","year":"2016","journal-title":"Dermatologic Surgery"},{"key":"e_1_2_12_79_1","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.3390\/app14167252","article-title":"Efficacy and Tolerability of a Microneedling Device Plus Exosomes for Treating Melasma","volume":"14","author":"Proietti I.","year":"2024","journal-title":"Applied Sciences"},{"key":"e_1_2_12_80_1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1468-3083.2011.04135.x","article-title":"Preventing Melasma Recurrence: Prescribing a Maintenance Regimen With an Effective Triple Combination Cream Based on Long\u2010Standing Clinical Severity","volume":"26","author":"Arellano I.","year":"2012","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_12_81_1","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/ijd.13782","article-title":"Dermatoscopic Evaluation and Histopathological Correlation of Acquired Dermal Macular Hyperpigmentation","volume":"56","author":"Vinay K.","year":"2017","journal-title":"International Journal of Dermatology"},{"key":"e_1_2_12_82_1","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1111\/jdv.15576","article-title":"Contact Sensitization to Hair Colours in Acquired Dermal Macular Hyperpigmentation: Results From a Patch and Photo\u2010Patch Test Study of 108 Patients","volume":"33","author":"Bishnoi A.","year":"2019","journal-title":"Journal of the European Academy of Dermatology and Venereology"},{"key":"e_1_2_12_83_1","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4103\/idoj.IDOJ_881_20","article-title":"Acquired Dermal Macular Hyperpigmentation: An Update","volume":"12","author":"Vinay K.","year":"2021","journal-title":"Indian Dermatology Online Journal"},{"key":"e_1_2_12_84_1","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70455","article-title":"The Efficacy of Platelet\u2010Rich Plasma in Facial Lichen Planus Pigmentosus: A Prospective Pilot Study","volume":"8","author":"Kiatsurayanon C.","year":"2025","journal-title":"Health Science Reports"},{"key":"e_1_2_12_85_1","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/lsm.23214","article-title":"Successful Treatment of Riehl's Melanosis With Mid\u2010Fluence Q\u2010Switched Nd:YAG 1064\u2010Nm Laser","volume":"52","author":"Cho M. Y.","year":"2020","journal-title":"Lasers in Surgery and Medicine"},{"key":"e_1_2_12_86_1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/pigmentinternational.pigmentinternational_1_23","article-title":"Impact of Postinflammatory Hyperpigmentation on Quality of Life in Patients With Skin of Color","volume":"11","author":"Bhattacharya I.","year":"2024","journal-title":"Pigment International"},{"key":"e_1_2_12_87_1","first-page":"1032","article-title":"Comparative Evaluation of Beneficiary Effects of Priming Agents (2% Hydroquinone and 0.025% Retinoic Acid) in the Treatment of Melasma With Glycolic Acid Peels","volume":"34","author":"Garg V. K.","year":"2008","journal-title":"Dermatologic Surgery"},{"key":"e_1_2_12_88_1","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/ics.12694","article-title":"Effective Reduction of Post\u2010Inflammatory Hyperpigmentation With the Tyrosinase Inhibitor Isobutylamido\u2010Thiazolyl\u2010Resorcinol (Thiamidol)","volume":"43","author":"Roggenkamp D.","year":"2021","journal-title":"International Journal of Cosmetic Science"},{"key":"e_1_2_12_89_1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/jocd.12549","article-title":"Association Between Clinical Characteristics, Quality of Life, and Sleep Quality in Patients With Periorbital Hyperchromia","volume":"18","author":"Barone C. R.","year":"2019","journal-title":"Journal of Cosmetic Dermatology"},{"key":"e_1_2_12_90_1","doi-asserted-by":"crossref","DOI":"10.3390\/cosmetics8020026","article-title":"Periorbital Hyperpigmentation\u2014Dark Circles Under the Eyes; Treatment Suggestions and Combining Procedures","volume":"8","author":"Goldman A.","year":"2021","journal-title":"Cosmetics"},{"key":"e_1_2_12_91_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.4103\/idoj.IDOJ_303_17","article-title":"Periorbital Hyperpigmentation: What Lies Beneath?","volume":"9","author":"Sarkar R.","year":"2018","journal-title":"Indian Dermatology Online Journal"},{"key":"e_1_2_12_92_1","first-page":"38","article-title":"Ferulic Acid Use for Skin Applications: A Systematic Review","volume":"18","author":"Roux J.","year":"2025","journal-title":"Journal of Clinical and Aesthetic Dermatology"},{"key":"e_1_2_12_93_1","volume-title":"Tranexamic Acid Tablets: Highlights of Prescribing Information","author":"Proficient Rx LP","year":"2025"},{"key":"e_1_2_12_94_1","unstructured":"Sun Pharmaceutical Industries Inc Isotretinoin Capsules: Highlights of Prescribing Information(2024) accessed May 12 2026 https:\/\/dailymed.nlm.nih.gov\/dailymed\/fda\/fdaDrugXsl.cfm?setid=b44200ba\u20106672\u20104ea7\u2010b151\u20107caec3f53c9c."},{"key":"e_1_2_12_95_1","doi-asserted-by":"crossref","first-page":"1006.e1","DOI":"10.1016\/j.jaad.2023.12.017","article-title":"Guidelines of Care for the Management of Acne Vulgaris","volume":"90","author":"Reynolds R. V.","year":"2024","journal-title":"Journal of the American Academy of Dermatology"},{"key":"e_1_2_12_96_1","volume-title":"CELLCEPT (Mycophenolate Mofetil): Highlights of Prescribing Information","author":"Genentech, Inc","year":"2025"},{"key":"e_1_2_12_97_1","article-title":"Standard Guidelines of Care for Chemical Peels","volume":"74","author":"Khunger N.","year":"2008","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"},{"key":"e_1_2_12_98_1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4103\/ijdvl.IJDVL_88_17","article-title":"Complications of Laser and Light\u2010Based Devices Therapy in Patients With Skin of Color","volume":"85","author":"Chandrashekar B. S.","year":"2019","journal-title":"Indian Journal of Dermatology, Venereology and Leprology"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.70531","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijd.70531","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijd.70531","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T11:21:34Z","timestamp":1781263294000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijd.70531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":97,"alternative-id":["10.1111\/ijd.70531"],"URL":"https:\/\/doi.org\/10.1111\/ijd.70531","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"2026-04-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"ijd.70531"}}